Arqaam Capital recommends Bupa Arabia stock as seven analysts rate it

Published on 10/20/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half profit reached SAR 694.1 million, up 4 percent year over year. November 3, 2026 is the next results date for Bupa Arabia stock.

Analyst action and operating milestones

Arqaam Capital's recommendation was published on October 19, 2026, alongside seven analyst analyses and an average target of SAR 181.83.
Bupa Arabia's first-half 2026 net profit reached SAR 694.1 million, an increase of 4 percent year over year.
The next financial results release is scheduled for November 3, 2026.

Bupa Arabia, SA1210540914, Illustration mit AI erstellt.

On October 19, 2026, Arqaam Capital recommended Bupa Arabia, while MarketScreener reported seven analyst analyses and an average target of SAR 181.83. The recommendation arrived as Bupa Arabia's first-half 2026 net profit stood at SAR 694.1 million, up 4 percent year over year.

Why the recommendation matters

The latest analyst action gives the stock a defined research catalyst, but the available report does not state a revised Arqaam Capital target or an earlier target for comparison. The broader consensus shown by MarketScreener was an average recommendation of Accumulate across seven analyses, with SAR 181.83 as the average target.

Argaam listed first-half 2026 profit at SAR 694.1 million and second-quarter profit at SAR 306.8 million. The same source reported first-half insurance revenue of SAR 10.54 billion, up 15.5 percent from SAR 9.13 billion in the comparable period.

Three dated company steps

On September 21, 2026, Bupa Arabia received final approval to market compulsory tourist visa insurance to individuals in Saudi Arabia, under product registration P-BUPA-2-I-26-015-compulsory, according to Attadawul.

On October 13, 2026, Bupa Arabia began trial operations at its first independent Riyadh clinic. Dawaa News said the clinic model covers 19 medical specialties and forms part of the Bupa CareConnect expansion.

On October 19, 2026, Arqaam Capital's buy recommendation became the latest dated research event, with MarketScreener showing seven analyst analyses and an average target of SAR 181.83.

When are the next results due?

The next scheduled financial results release is November 3, 2026, according to TennisTonic. That date gives investors the next formal checkpoint for insurance growth, profit development and the early contribution of the clinic strategy.

What comes next for Bupa Arabia

Bupa Arabia combines its core health insurance business with direct-care initiatives, making the November update relevant beyond the headline profit figure. The key measurable comparison is the gap between first-half insurance revenue growth of 15.5 percent and net profit growth of 4 percent.

Bupa Arabia was last at SAR 134.30 on Tadawul on October 20, 2026 at 11:28 a.m. AST. Its market capitalization was SAR 20.1 billion, with a 52-week range of SAR 131.40 to SAR 200.00 as of October 20, 2026.